Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TELA | Common Stock, par value $0.001 per share | Purchase | $124K | +10K | +0.55% | $12.43 | 1.83M | Sep 15, 2021 | See footnotes | F1, F2, F3 |
Id | Content |
---|---|
F1 | Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer. |
F2 | EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. |
F3 | This Amended Form 4 is filed only to correct the date set forth in the original Form 4 filed on September 17, 2021. No other change has been made to the original Form 4 filed on September 17, 2021 relating to the trade made on September 15, 2021. |